← All procedure guides

Diabetic kidney disease management

Ongoing treatment to slow kidney damage caused by diabetes and to lower the linked risk of heart and circulation problems.

✓ Medically reviewed by a GMC-registered consultant · last reviewed September 2026 · next review September 2027 · how we review

In short

  • The goal is to slow kidney damage and protect the heart, not to cure or reverse the disease.
  • Most plans combine blood-sugar control, blood-pressure control, and kidney-protecting medicines such as ACE inhibitors/ARBs and SGLT2 inhibitors.
  • Progress is judged over months and years using kidney blood tests (eGFR) and a urine protein test (ACR), not one appointment.
  • Starting or changing these medicines needs blood tests to check kidney function and potassium, so monitoring matters as much as the prescription.

A plain-English summary. The detail — including risks and recovery — is below.

At a glance

TypeMedical treatment (ongoing condition management)
AnaestheticNot needed
How long it takesLong-term: clinic reviews plus daily medicines
Hospital stayOutpatient — no hospital stay for routine care
Time off workUsually none for appointments
When you'll see resultsKidney function and urine protein are tracked over months and years, not single visits
On the NHS?Widely managed on the NHS by GPs and kidney teams; private care is used mainly for speed of review, choice of specialist or a second opinion

A general guide. Your specialist will give you advice for your situation.

Best fit

Can slow how quickly kidney function declines over the years

Pause if

Some kidney-protecting medicines are not suitable, or need stopping, when kidney function is very low or potassium is high.

Main recovery point

You may be asked to have a blood test 1–2 weeks after starting or increasing an ACE inhibitor, ARB or similar, to check kidney function and potassium...

Good aftercare

A clear, written plan with your targets, medicines and next test dates.

First weeks after a medicine change

You may be asked to have a blood test 1–2 weeks after starting or increasing an ACE inhibitor, ARB or similar, to...

First few months

Blood pressure, blood sugar and urine protein are reviewed to see whether the plan is working. Doses may be...

6–12 months

The trend in kidney function (eGFR) and urine protein (ACR) is reviewed to judge whether the kidneys are stable...

Year on year

Long-term monitoring continues, usually at least once a year and more often if kidneys are declining. The plan is...

Medical line illustration of kidney cross section filtering unit for Diabetic kidney disease management.
Illustration only - not a diagnosis, medical advice or a promise of result. Your anatomy and treatment plan may differ. Vuemedics does not publish before-and-after photos.

What is diabetic kidney disease management?

Diabetes can slowly damage the tiny filters in the kidneys. Over years this can let protein leak into the urine and make the kidneys work less well. This is called diabetic kidney disease, or diabetic nephropathy. Managing it means using medicines and lifestyle changes to slow that damage and to protect your heart and blood vessels, which are at higher risk too.

There is usually no single treatment and no quick fix. The aim is to keep the condition stable for as long as possible. Most plans combine good control of blood sugar and blood pressure, a kidney-protecting tablet such as an ACE inhibitor or ARB, and often an SGLT2 inhibitor (a tablet first developed for diabetes that also protects the kidneys).

Management can slow how fast the kidneys decline and lower the chance of needing dialysis or a transplant in the future. It cannot reliably reverse damage that has already happened, and not everyone responds in the same way.

Much of this care is straightforward and done by a GP or practice nurse. Some people are referred to a kidney specialist (nephrologist) when the kidneys are declining faster, when results are hard to explain, or when stronger treatment is being considered.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Blood-pressure and kidney-protecting medicines
An ACE inhibitor or ARB is usually the foundation. These lower blood pressure and reduce protein leaking into the urine, which helps protect the kidneys. Blood tests check kidney function and potassium after starting or increasing the dose.
SGLT2 inhibitors
Tablets such as dapagliflozin or empagliflozin, first used for diabetes, that also slow kidney decline and lower heart risk. They are now offered to many people with diabetic kidney disease, often alongside an ACE inhibitor or ARB.
Blood-sugar (glucose) management
Keeping glucose in an agreed range, using diet, tablets, non-insulin injections or insulin. Targets are personalised; very tight control is not always safer.
Finerenone and other add-on medicines
For some people with type 2 diabetes and protein in the urine, an additional tablet such as finerenone may be added on top of standard treatment. It needs careful potassium monitoring.
Lifestyle and risk-factor support
Stopping smoking, reducing salt, weight management, activity, and cholesterol treatment all help protect both the kidneys and the heart.
Planning for advanced kidney disease
If kidneys decline a lot over time, the team plans ahead and discusses options such as dialysis or transplant, or supportive care, well before they are needed.

NHS and private routes for kidney care in diabetes

FeatureNHS pathwayPrivate pathway
Who manages itGP, practice nurse, kidney clinic if neededPrivate GP or nephrologist, can self-refer
Speed of reviewRoutine; urgent if results worsenOften faster appointment
Medicines usedSame evidence-based medicinesSame evidence-based medicines
Ongoing monitoringRecall system for blood and urine testsArranged privately; share results with your GP

The medicines and targets are the same whoever prescribes them. If you see a private specialist, keep your GP informed so monitoring and prescriptions stay joined up.

Preparing for your treatment

  • Bring a full list of your medicines, including blood-pressure tablets, diabetes treatment, painkillers and any supplements.
  • Bring recent blood pressure, blood sugar and HbA1c readings if you have them.
  • Bring or ask for recent kidney blood tests (eGFR/creatinine) and urine protein tests (ACR).
  • Note any swelling, breathlessness, foaming urine, or how often you pass urine at night.
  • Tell the team about episodes of dehydration, vomiting, diarrhoea, or recent scans using contrast dye.
  • List anti-inflammatory painkillers (such as ibuprofen) you take, as these can affect the kidneys.
  • Have a clear question in mind, such as how fast your kidneys are changing and what your targets are.

What happens

A typical review starts with your history, symptoms and recent readings. The clinician checks your blood pressure and may examine you for fluid build-up, such as swollen ankles.

You will usually have a blood test for kidney function (eGFR and creatinine) and a urine test for protein (ACR), plus other blood tests such as potassium, blood sugar control (HbA1c) and sometimes cholesterol. These results show whether the kidneys are stable or changing.

The clinician then agrees a plan with you: which medicines to start, continue or adjust, your blood-pressure and glucose targets, and when to repeat the tests. If a new kidney-protecting medicine is started, you are usually asked to have a repeat blood test a week or two later to check kidney function and potassium.

You normally leave with a clear plan, a date for the next blood tests, and advice on what changes should prompt you to get in touch sooner.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

May not be suitable if…

  • Some kidney-protecting medicines are not suitable, or need stopping, when kidney function is very low or potassium is high.
  • Very tight blood-sugar control may not suit older or frailer people, where the risk of hypos can outweigh the benefit.
  • ACE inhibitors and ARBs should not usually be combined, and are avoided in pregnancy.
  • If symptoms point to a sudden kidney problem rather than long-term diabetic kidney disease, urgent assessment is needed instead of routine management.
  • An SGLT2 inhibitor may not be appropriate where there is a high risk of diabetic ketoacidosis or recurrent genital infections.

Delay or rearrange if…

  • You are acutely unwell, dehydrated, or have vomiting or diarrhoea — some medicines are paused first.
  • You are pregnant or planning pregnancy, as several of these medicines must be reviewed.
  • Your potassium is high and needs correcting before adding or increasing certain medicines.
  • Recent results are missing, so the team cannot safely judge kidney function before changing treatment.
  • You have just had a scan with contrast dye or a recent illness affecting the kidneys.

Alternatives to discuss

  • Lifestyle measures alone (salt reduction, weight, activity, stopping smoking) where the disease is very mild.
  • Optimising existing diabetes and blood-pressure treatment before adding new medicines.
  • Referral to a kidney specialist for a tailored plan if the GP-led approach is not enough.
  • Supportive (conservative) kidney care without dialysis for some people with advanced disease, as a planned choice.
  • Watchful monitoring with clear review intervals where the balance of treatment is uncertain.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

What matters most to me?

Think about symptoms, daily life, work, caring responsibilities, sport, fertility, travel, appearance and anxiety — the right choice depends on your priorities, not just the medical facts.

What are all my options?

Ask about waiting, monitoring, medicines, rehabilitation, a smaller or larger procedure, a different test, NHS referral, or a second opinion where that would help.

What would make me pause?

Active infection, pregnancy, unstable medical problems, smoking, medicines that increase bleeding, poor support at home, or feeling pressured are all reasons to slow down and get tailored advice.

What happens if I do nothing today?

For some problems, waiting is safe; for others, delay can make treatment harder. A good consultation should explain the trade-off in plain English.

Benefits

  • Can slow how quickly kidney function declines over the years
  • Reduces protein leaking into the urine, a marker of kidney stress
  • Lowers the risk of heart attack, stroke and heart failure, which are linked to kidney disease
  • May delay or reduce the chance of needing dialysis or a transplant
  • Helps detect and treat complications such as anaemia, high potassium or bone problems early
  • Gives you clear targets and a plan you can act on

Risks & complications

More common
  • Side effects from blood-pressure medicines, such as dizziness, a dry cough (with ACE inhibitors) or feeling lightheaded
  • Genital thrush or urinary symptoms with SGLT2 inhibitors, especially early on
  • Low blood sugar (hypos) if diabetes treatment is intensified, particularly with insulin or some tablets
  • Needing frequent blood tests and clinic visits
Less common
  • A rise in potassium, which may need a medicine change or extra monitoring
  • A temporary drop in kidney function after starting or increasing some medicines
  • Dehydration during illness, which can affect the kidneys (so-called 'sick day' situations)
  • Low blood pressure causing falls in older or frailer people
Rare but serious
  • Diabetic ketoacidosis with SGLT2 inhibitors, which can occur even with near-normal blood sugar and needs urgent care
  • Severe allergic swelling (angioedema) with ACE inhibitors
  • Serious high potassium causing heart rhythm problems

The biggest practical issues are potassium levels, dehydration during illness, and balancing tight blood-sugar control against the risk of hypos. Ask your clinician what your targets are, what 'sick day rules' apply to your medicines, and exactly when to pause a tablet and seek advice. Avoid regular anti-inflammatory painkillers unless your clinician agrees.

Published figures to discuss

How diabetic kidney disease behaves varies widely from person to person, depending on how long someone has had diabetes, blood-sugar and blood-pressure control, how much protein is in the urine, and other health conditions. Because individual risk is so variable, reliable single percentages for outcomes such as progression or starting dialysis are not meaningful for an individual, and broad trial averages can be misleading when applied to one person.

FigureReported rangeHow to interpret itSource / confidence
Albuminuria before eGFR fallsCommon early patternUrine ACR can detect diabetic kidney damage before standard kidney blood tests look abnormal.Guide sourcesClinical context
Progression to kidney failureStrongly depends on ACR, eGFR, blood pressure and glucose controlACE inhibitors/ARBs, SGLT2 inhibitors where suitable, BP control and diabetes care reduce risk.Diabetes UK — Diabetic nephropathy (kidney disease)diabetes.org.ukSource-linked context
Cardiovascular diseaseMajor competing riskDiabetic kidney disease greatly increases heart and stroke risk, so lipid, smoking and BP management are central.Diabetes UK — Diabetic nephropathy (kidney disease)diabetes.org.ukSource-linked context
Hyperkalaemia or creatinine rise after kidney-protective medicinesRecognised monitoring issueBlood tests are needed after starting or increasing ACE inhibitors/ARBs, MRAs or some other kidney medicines.Guide sourcesClinical context

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

This is ongoing management rather than a one-off treatment, so there is no recovery period. Instead, the focus is on how you respond to treatment over time and how your results are monitored.

First weeks after a medicine change
You may be asked to have a blood test 1–2 weeks after starting or increasing an ACE inhibitor, ARB or similar, to check kidney function and potassium. Some side effects, such as thrush with SGLT2 inhibitors, tend to show early.
First few months
Blood pressure, blood sugar and urine protein are reviewed to see whether the plan is working. Doses may be fine-tuned. A small, stable dip in kidney function after starting some medicines can be expected and is not always a bad sign.
6–12 months
The trend in kidney function (eGFR) and urine protein (ACR) is reviewed to judge whether the kidneys are stable. Other checks, such as for anaemia or bone health, may be added as needed.
Year on year
Long-term monitoring continues, usually at least once a year and more often if kidneys are declining. The plan is updated as your health, other conditions and priorities change.
What's normal — and not a worry
  • No immediate change in how you feel — kidney protection works quietly in the background
  • Passing more urine at first when starting an SGLT2 inhibitor
  • A small, stable drop in kidney function on blood tests after starting some medicines
  • Needing regular blood and urine tests as part of normal care
  • Occasional dose changes as results and blood pressure settle

Aftercare

  • Take kidney-protecting medicines as prescribed and do not stop them suddenly without advice.
  • Attend blood and urine tests on time — they are how the plan is judged.
  • Follow any 'sick day rules' you are given: some medicines are paused during vomiting, diarrhoea or dehydration.
  • Keep blood pressure and blood sugar within your agreed targets where you can.
  • Reduce salt, avoid regular anti-inflammatory painkillers, and stay well hydrated unless told otherwise.
  • Tell any clinician arranging a scan with contrast dye that you have kidney disease.
  • Keep your GP and any private specialist informed of each other's plans and results.
  • Know who to contact if you feel unwell or your symptoms change.
Before your treatment
  • Up-to-date list of all medicines and supplements
  • Recent eGFR and urine ACR results to hand
  • Home blood-pressure readings if you monitor
  • Written 'sick day rules' for your medicines
  • A named contact route for questions or worsening symptoms
  • Next blood-test and review date booked
  • Your GP's details to share specialist letters

⚠ Get urgent help if…

  • Vomiting, diarrhoea or being unable to keep fluids down — you may need to pause certain medicines and seek advice
  • Feeling very unwell with nausea, deep or fast breathing, or tummy pain (possible diabetic ketoacidosis) — seek urgent help
  • Passing very little or no urine
  • Sudden swelling of the legs, breathlessness, or being unable to lie flat
  • Muscle weakness, palpitations or a very slow pulse (possible high potassium)
  • Fainting, repeated dizziness or falls
  • Signs of a urinary or genital infection that is spreading or not settling

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result is kidney function that stays stable, or declines only slowly, with less protein in the urine and well-controlled blood pressure and blood sugar. These are judged over time using repeated tests, not a single visit.

Management cannot guarantee that the kidneys will never get worse, and it usually cannot reverse damage already done. Even with good treatment, some people's kidneys still decline, which is why monitoring continues and plans are reviewed.

How long it lasts

Diabetic kidney disease is a long-term condition, so management continues for life. How well the kidneys hold up depends on many things, including blood-sugar and blood-pressure control, how much protein is in the urine, other health conditions, and how the disease behaves in you. Targets and medicines are reviewed regularly as your situation changes.

Related tests, treatments or support

Care for diabetic kidney disease usually sits alongside management of diabetes itself, blood pressure, cholesterol and heart health, because these are closely linked. Some people also need treatment for related complications such as anaemia of kidney disease, bone and mineral problems, or high potassium. Good care joins these together rather than treating each in isolation.

Follow-up & long-term care

Follow-up is mainly through repeat blood and urine tests and clinic or GP reviews. After a medicine change you may be re-tested within a week or two; otherwise reviews are typically at least yearly, and more often if the kidneys are declining or treatment is being adjusted. Results should be explained to you, and any private specialist input should be shared with your GP.

  • Regular kidney blood tests (eGFR/creatinine) and urine protein tests (ACR)
  • Potassium checks, especially after medicine changes
  • Blood-pressure and blood-sugar (HbA1c) monitoring
  • Periodic checks for anaemia, bone health and cholesterol as advised
  • Annual review of medicines, vaccinations and overall plan
  • Updating your 'sick day rules' if medicines change

Repeat, follow-on and what comes next

  • Treatment is regularly adjusted: doses are titrated, medicines are added or switched, and targets change as results and health change.
  • A medicine sometimes has to be stopped because of side effects such as high potassium, a cough or low blood pressure.
  • Despite good treatment, some people's kidneys still decline and need escalation or planning for advanced kidney care.
  • Monitoring is lifelong because the plan only works if it is reviewed and updated over time.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

  • A clear, written plan with your targets, medicines and next test dates.
  • A named contact route for questions, side effects or worsening symptoms.
  • Reliable recall for blood and urine tests, with results explained to you.
  • Written 'sick day rules' and advice on which medicines to pause when unwell.
  • Joined-up communication between your GP and any private or hospital specialist.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

  • Whether you see a GP, a specialist nurse or a consultant nephrologist
  • Length and frequency of appointments and how complex your case is
  • Blood and urine tests, and how often they are repeated
  • Any additional tests such as kidney ultrasound or further investigations
  • Medicines prescribed, some of which are inexpensive and some newer
  • Whether follow-up, monitoring and result letters are included
  • Coordination with your GP and any other specialists involved
Make sure your written quote includes
  • The consultant or clinician fee for each appointment
  • Which blood and urine tests are included and how often
  • The cost and arrangements for any additional scans or tests
  • Whether medicines and their monitoring are included or separate
  • What ongoing follow-up and review is included
  • How results and letters are shared with you and your GP
  • What happens, and what it costs, if results are unclear or you become unwell

On the NHS? Diabetic kidney disease is routinely managed on the NHS by GPs and kidney teams when clinically indicated; private care is generally used for speed, choice of specialist or a second opinion rather than for different medicines.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Choosing a specialist safely

  • Check the specialist is on the GMC Specialist Register for this area.
  • Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
  • You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
  • Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
  • You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Questions to ask your medical professional

Take this to your consultation. A good specialist will welcome every one of these.

  • How fast are my kidneys changing, based on my eGFR and urine protein over time?
  • What are my personal blood-pressure and blood-sugar targets, and why?
  • Which of my medicines protect my kidneys, and what are their main risks for me?
  • Should I be on an SGLT2 inhibitor or another add-on, and what are the trade-offs?
  • What are my 'sick day rules', and exactly when should I pause a medicine or seek help?
  • When will my tests be repeated, and who will explain the results?
  • At what point would I be referred to, or need, a kidney specialist?
  • Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
  • Will you be the specialist who carries out my treatment, and who looks after me afterwards?
  • What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
  • What does a realistic result look like — and what can this treatment not achieve?
  • What are my options, including waiting, doing nothing for now, or choosing a different approach?
  • Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
  • What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Frequently asked questions

Can diabetic kidney disease be cured or reversed?
It usually cannot be reversed, but it can often be slowed. The aim of treatment is to protect the kidneys and heart and keep things stable for as long as possible.
Is this treated on the NHS or do I need to go private?
Most diabetic kidney disease is managed on the NHS by GPs and, where needed, kidney specialists. People sometimes choose private care for a faster appointment, a particular specialist or a second opinion, but the medicines and targets are the same.
Why do I need so many blood tests?
Blood and urine tests are how the team judges whether the kidneys are stable and whether medicines are safe — for example, by checking kidney function and potassium after a dose change.
Will I definitely need dialysis?
Many people never need dialysis. Good management can delay or reduce that risk, but it cannot promise it for everyone, which is why monitoring continues over time.
Why might my kidney function drop a little when I start a new tablet?
Some kidney-protecting medicines cause a small, stable dip in kidney function at first that is expected and not harmful. Your clinician checks this with a blood test and explains what is normal for you.
Are painkillers safe?
Regular anti-inflammatory painkillers such as ibuprofen can harm the kidneys and are best avoided unless your clinician agrees. Always check before taking them regularly.
What are 'sick day rules'?
These are instructions to pause certain medicines, such as some kidney and diabetes drugs, if you become dehydrated through vomiting, diarrhoea or fever, and when to seek help. Ask your team for a written version.

Find a verified specialist for diabetic kidney disease management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NICE NG203 — Chronic kidney disease: assessment and management UK Kidney Association — Management of patients with CKD Diabetes UK — Diabetic nephropathy (kidney disease) NHS — Chronic kidney disease NICE TA877 — Finerenone for CKD in type 2 diabetes

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.

Related guides: Anaemia of kidney disease management · Electrolyte disorder assessment · Acute kidney injury treatment · Chronic kidney disease treatment · Glomerulonephritis management